Search
for
Sort by
Research 361–390 of 1000+
- Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata
- Genetic links between atopy, allergy, and alopecia areata: insights from a Mendelian randomization study
- Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
- Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis
- The Role of Patients in Alopecia Areata Endpoint Development: Understanding Physical Signs and Symptoms
- Comparison of Dermatology Life Quality Index Scores in Adults and Adolescents with Alopecia Areata
- Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety
- Upadacitinib Therapy in Adolescent Severe Alopecia Areata: A Case Series and Narrative Review
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA
- Efficacy and safety of tofacitinib in patients with alopecia areata
- Nail Involvement in Pediatric Alopecia Areata: Clinical and Onychoscopic Features: A Serie of 42 Cases
- Treatment Outcomes of Triamcinolone Acetonide Compared with Cryotherapy in Alopecia Areata: Evidence from a Systematic Review and Meta-Analysis
- Hair for the Long Haul: Alopecia Areata Cases and Considerations
- Baricitinib Provides Holistic Improvement in Scalp, Eyebrow and Eyelash Regrowth in Adolescents With Severe Alopecia Areata
- Serum level of calprotectin as a new inflammatory marker in patients with alopacia areata
- Prediction of Long-term Scalp Hair Regrowth at 24 Months in Patients with Alopecia Areata Receiving Ritlecitinib Treatment in the ALLEGRO Clinical Trial Program
- Efficacy of Ritlecitinib in Patients with Alopecia Areata by Extent of Hair Loss: Results from the Phase 2b/3 and Phase 3 ALLEGRO Clinical Trials
- Depression among Alopecia Areata Patients: Prevalence and associated factors in a Tunisian sample
- Parenting Styles and Psychological Effects on Children with Alopecia Areata: Exploring Family Dynamics, Anxiety, and Depression
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- The Efficacy of Azelaic Acid 20% Cream in the Treatment of Scalp Alopecia Areata
- Use of trichoscopy for the diagnosis of alopecia areata coexisting with primary scarring alopecia in a female hair loss patient
- Baricitinib in the Management of Severe Alopecia Areata: A Report of Two Cases With Sustained Clinical Response
- COMPARATIVE EFFICACY OF TOPICAL CLOBETASOL PROPIONATE 0.05% OINTMENT AND TOPICAL TACROLIMUS 0.1% OINTMENT IN THE TREATMENT OF ALOPECIA AREATA
- Efficacy and safety of tofacitinib in pediatric patients with alopecia areata: A prospective cohort study
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- Korean Consensus Criteria for the Severity Classification of Alopecia Areata
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis